Family‐Wise Error Rate Control in Clinical Trials With Overlapping Populations
Remi Luschei, Werner Brannath · 2026
Read Family‐Wise Error Rate Control in Clinical Trials With Overlapping Populations by Remi Luschei, Werner Brannath (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13507661.txt.
Description
Remi Luschei and Werner Brannath published a statistics paper in 2026. They study error control in multi-population clinical trials. Some trials test treatments in overlapping patient groups. Each group may receive its own tailored policy. False positive claims could then harm several groups. Trials usually control the family-wise error rate. That rate is the chance of any false rejection. Standard adjustments assume equal null effects everywhere. The authors show that assumption can fail badly.
When opposite effects cancel across groups, control breaks. Tests may reject true null claims too often. The standard method no longer protects the error rate. Alternative procedures are proposed and compared directly. Power and error control are weighed for each option. Trial designers should check the cancelling case carefully. Safer methods exist for overlapping population designs.
Catalog record
| CREATOR | Remi Luschei, Werner Brannath |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |